Updated:
Kleinmuntz Associates
Kleinmuntz Associates LLC is a closely-held venture capital firm founded in 2013 and based in Chicago. The firm specializes in early-stage start-up investments...
Kleinmuntz Associates
Kleinmuntz Associates LLC is a closely-held venture capital firm founded in 2013 and based in Chicago. The firm specializes in early-stage start-up investments at the intersection of analytics, biotechnology, and healthcare. Its investment approach combines capital deployment with active business advisory services to support portfolio companies. Principals Dr. Catherine and Don Kleinmuntz bring decades of healthcare and analytics expertise, having previously co-founded Strata Decision Technology. The firm has made 4 investments to date. One of its portfolio companies includes VedaBio, which received a Seed VC investment on October 17, 2023. VedaBio is currently developing a breakthrough platform for near-instant molecular detection of highly multiplexed analytes.
General information
Firm type
Early Stage
Location
Region
North America
Country
United States
City
Chicago
Corporate office
Chicago, United States
Sector focus
Frequently asked questions
What is the investment focus of Kleinmuntz Associates?
The firm focuses on early-stage start-up investments at the intersection of analytics, biotechnology, and healthcare.
Who are the principals of Kleinmuntz Associates?
Dr. Catherine Kleinmuntz and Dr. Don Kleinmuntz are the principals of the firm.
What notable company is in the Kleinmuntz Associates portfolio?
Kleinmuntz Associates made a Seed VC investment in VedaBio on October 17, 2023, a company developing a near-instant molecular detection platform.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: